Citadel Advisors »

Eliem Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $956k 239k 4.00
2025-06-30 $172k 138k 1.24
2025-03-31 $101k 83k 1.22
2024-12-31 $120k 67k 1.80
2022-06-30 $46k 15k 3.02

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
ADAR1 Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Dr. Jeffrey R. Jay, M.D.
Sphera Funds Management
Point72 Asset Management
Driehaus Capital Management
Two Sigma Investments
Peapod Lane Capital
Nan Fung Trinity
Susquehanna International
BlackRock

View all funds holding Eliem Therapeutics